MODIFIED ACTRII PROTEINS AND METHODS OF USE THEREOF

Number of patents in Portfolio can not be more than 2000

United States of America

APP PUB NO 20250041385A1
SERIAL NO

18717939

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

An isolated protein comprising a mutant soluble activin II receptor (ActRIIA or ActRIIB) extracellular domain (Ac-tRIIA-ECD or ActRIIB-ECD), wherein said mutant soluble ActRIIA-ECD or ActRIIB-ECD comprises a mutation to remove the N-linked glycosylation site corresponding to position N18 of SEQ ID NO: 1.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • BIOGEN MA INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
ARNDT, Joseph Walter Swampscott, US 3 0
DALKILIC-LIDDLE, Isin Watertown, US 4 0
LIU, YuTing Belmont, US 37 83
PEPINSKY, R Blake Arlington, US 87 1837
SMITH, Benjamin Andrew Belmont, US 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation